GTR Test Accession:
Help
GTR000603797.2
Last updated in GTR:
2023-04-20
View version history
GTR000603797.2,
last updated:
2023-04-20
GTR000603797.1,
registered in GTR:
2023-01-09
Last annual review date for the lab: 2024-05-28
LinkOut
At a Glance
Methods (1):
Help
Biochemical Genetics - Analyte: Gas chromatography–mass spectrometry (GC-MS)
Target population: Help
Investigation of possible desmosterolosis (desmosterol reductase deficiency), cerebrotendinous xanthomatosis, lathosterolosis, …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Establish or confirm diagnosis, Guidance for management
Ordering Information
Offered by:
Help
Test short name:
Help
STER
Specimen Source:
Help
- Plasma
- View specimen requirements
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Dentist
- Licensed Physician
- Nurse Practitioner
- Physician Assistant
- Public Health Mandate
- Registered Nurse
Test Order Code:
Help
Lab contact:
Help
Gisele (Gessi) Bentz Pino, MS, CGC, Certified Genetic counselor, CGC, Genetic Counselor
[email protected]
1-800-533-1710
[email protected]
1-800-533-1710
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
https://www.mayocliniclabs.com/test-catalog/overview/82079#Specimen
Order URL
Order URL
Test development:
Help
Test developed by laboratory (no manufacturer test name)
Informed consent required:
Help
Based on applicable state law
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test strategy
Conditions
Help
Total conditions: 6
Condition/Phenotype | Identifier |
---|
Test Targets
Analytes
Help
Total analytes: 11
Analyte | Associated Condition |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Analyte
Gas chromatography–mass spectrometry (GC-MS)
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis;
Screening
Clinical utility:
Help
Target population:
Help
Investigation of possible desmosterolosis (desmosterol reductase deficiency), cerebrotendinous xanthomatosis, lathosterolosis, sitosterolemia, sterol C4 methyl oxidase deficiency, MEND (male EBP disorder with neurologic defects) syndrome, and X-linked chondrodysplasia punctata 2
View citations (2)
- Herman GE, Kratz L. Disorders of sterol synthesis: beyond Smith-Lemli-Opitz syndrome. Am J Med Genet C Semin Med Genet. 2012;160C(4):301-21. doi:10.1002/ajmg.c.31340. Epub 2012 Oct 05. PMID: 23042573.
- Bjorkhem I, Boberg KM, Leitersdorf El: Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Valle D, Antonarakis S, Ballabio A, Beaudet AL, Mitchell GA, eds. The Online Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill; 2019. Accessed November 10, 2020. Available at http://ommbid.mhmedical.com/content.aspx?bookid=971§ionid=62638585
Recommended fields not provided:
Clinical validity,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Procedure:
Help
The plasma specimen is hydrolyzed and then extracted, followed by evaporation to dryness under nitrogen. The sterols are derivatized and analyzed using selected ion-monitoring electron impact gas chromatography-mass spectrometry (GC-MS) to quantitate 7-dehydrocholesterol, 8-dehydrocholesterol, squalene, 8(9)-cholestenol, cholestanol, desmosterol, lathosterol, DiHydro T-MAS (testis meiosis activating sterol), campesterol, stigmasterol, and sitosterol.(Unpublished Mayo …
View more
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Recovery was used to assess accuracy; mean recovery was 104%. Intra assay precision was performed at 3 levels: CV results ranged from 3.2%-13.9% (N=20 each). Inter assay precision was performed at 3 levels: CV results ranged from 3.8%-19.6% (N=20 each). The analytical measurement range varies per analyte but ranges from …
View more
Assay limitations:
Help
Reference values were derived using fasting specimens from healthy individuals. Sitosterol and campesterol values may be mildly elevated in individuals whose diets include foods with high concentrations of plant sterols, such as some vegetable oils and infant formulas. Desmosterol may be elevated in individuals on medications containing amiodarone. (1) Seven-dehydrocholesterol …
View more
View citations (3)
- Lupattelli G, De Vuono S, Mannarino E. Patterns of cholesterol metabolism: pathophysiological and therapeutic implications for dyslipidemias and the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2011;21(9):620-7. doi:10.1016/j.numecd.2011.04.010. Epub 2011 Aug 19. PMID: 21855307.
- Hall P, Michels V, Gavrilov D, Matern D, Oglesbee D, Raymond K, Rinaldo P, Tortorelli S. Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome. Mol Genet Metab. 2013;110(1-2):176-8. doi:10.1016/j.ymgme.2013.04.004. Epub 2013 Apr 10. PMID: 23628460.
- Simonen P, Lehtonen J, Lampi AM, Piironen V, Stenman UH, Kupari M, Gylling H. Desmosterol accumulation in users of amiodarone. J Intern Med. 2018;283(1):93-101. doi:10.1111/joim.12682. Epub 2017 Sep 21. PMID: 28861933.
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
European Research Network for the Evaluation and Improvement of Screening Diagnosis and Treatment of Inherited Metabolic Disorders - External Quality Assessment Schemes, ERNDIM EQAS
Description of PT method: Help
Formal PT program and Inter-laboratory comparison with outside laboratory(s)
Description of internal test validation method: Help
This test was laboratory developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements.
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
European Research Network for the Evaluation and Improvement of Screening Diagnosis and Treatment of Inherited Metabolic Disorders - External Quality Assessment Schemes, ERNDIM EQAS
Description of PT method: Help
Formal PT program and Inter-laboratory comparison with outside laboratory(s)
Description of internal test validation method: Help
This test was laboratory developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements.
Recommended fields not provided:
Test Confirmation,
Citations to support internal test validation method,
Citations for Analytical validity,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Clinical resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.